Yu Shuisheng, Cheng Li, Tian Dasheng, Li Ziyu, Yao Fei, Luo Yang, Liu Yanchang, Zhu Zhenyu, Zheng Meige, Jing Juehua
Department of Orthopaedics, The Second Hospital of Anhui Medical University, Hefei, China.
School of Pharmacy, Anhui Medical University, Hefei, China.
Front Pharmacol. 2021 Sep 27;12:729524. doi: 10.3389/fphar.2021.729524. eCollection 2021.
Recent research indicates that after spinal cord injury (SCI), microglia accumulate at the borders of lesions between astrocytic and fibrotic scars and perform inflammation-limiting and neuroprotective functions, however, the mechanism of microglial migration remains unclear. Fascin-1 is a key actin-bundling protein that regulates cell migration, invasion and adhesion, but its role during SCI has not been reported. Here, we found that at 7-14 days after SCI in mice, Fascin-1 is significantly upregulated, mainly distributed around the lesion, and specifically expressed in CX3CR1-positive microglia. However, Fascin-1 is not expressed in GFAP-positive astrocytes, NeuN-positive neurons, NG2-positive cells, PDGFRβ-positive cells, or blood-derived Mac2-positive macrophages infiltrating into the lesion core. The expression of Fascin-1 is correspondingly decreased after microglia are specifically depleted in the injured spinal cord by the colony-stimulating factor 1 receptor (CSF1R) inhibitor PLX5622. The upregulation of Fascin-1 expression is observed when microglia are activated by myelin debris , and microglial migration is prominently increased. The inhibition of Fascin-1 expression using small interfering RNA (siRNA) markedly suppresses the migration of microglia, but this effect can be reversed by treatment with myelin. The M1/M2-like polarization of microglia does not affect the expression of Fascin-1. Together, our results suggest that Fascin-1 is highly expressed specifically in microglia after SCI and can play an important role in the migration of microglia and the formation of microglial scars. Hence, the elucidation of this mechanism will provide novel therapeutic targets for the treatment of SCI.
近期研究表明,脊髓损伤(SCI)后,小胶质细胞聚集在星形胶质瘢痕和纤维化瘢痕之间的损伤边界处,并发挥限制炎症和神经保护功能,然而,小胶质细胞迁移的机制仍不清楚。Fascin-1是一种关键的肌动蛋白束蛋白,可调节细胞迁移、侵袭和黏附,但其在脊髓损伤中的作用尚未见报道。在此,我们发现小鼠脊髓损伤后7-14天,Fascin-1显著上调,主要分布在损伤周围,并在CX3CR1阳性小胶质细胞中特异性表达。然而,Fascin-1在GFAP阳性星形胶质细胞、NeuN阳性神经元、NG2阳性细胞、PDGFRβ阳性细胞或浸润到损伤核心的血源性Mac2阳性巨噬细胞中不表达。通过集落刺激因子1受体(CSF1R)抑制剂PLX5622特异性清除损伤脊髓中的小胶质细胞后,Fascin-1的表达相应降低。当小胶质细胞被髓磷脂碎片激活时,可观察到Fascin-1表达上调,且小胶质细胞迁移显著增加。使用小干扰RNA(siRNA)抑制Fascin-1表达可显著抑制小胶质细胞迁移,但这种作用可通过髓磷脂处理逆转。小胶质细胞的M1/M2样极化不影响Fascin-1的表达。总之,我们的结果表明,Fascin-1在脊髓损伤后小胶质细胞中特异性高表达,可在小胶质细胞迁移和小胶质瘢痕形成中发挥重要作用。因此,阐明这一机制将为脊髓损伤的治疗提供新的治疗靶点。